About
Checkpoint Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
90
By Phase
PHASE1/PHASE2: 2
By Status
NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05566223Lead Sponsor
CISH Inactivated TILs in the Treatment of NSCLC
PHASE1/PHASE2Not yet recruiting
70 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2027
NCT04426669Lead Sponsor
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
PHASE1/PHASE2Active, not recruiting
20 participants
Started: May 15, 2020 · Completed: Jan 31, 2026
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...